Structure Therapeutics Inc.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small…
Biotechnology
US, South San Francisco [HQ]
Balance Sheet
4 Sheets · Starting from 2020In Million USD. Margins, Growth Rates In %
| Metric | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Assets | - - | - - | 97.00 | 482.00 | |
|
Current
|
- - | - - | 93.00 | 473.00 | |
| Cash And Equivalents | - - | - - | 90.00 | 129.00 | |
| Assets | - - | - - | 97.00 | 482.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | |
| Inventory | - - | - - | - - | - - | |
| Short Term Investments | - - | - - | 64.00 | 337.00 | |
| Other Current Assets | - - | 1.00 | 2.00 | 6.00 | |
|
Non Current
|
- - | - - | 4.00 | 8.00 | |
| Property, Plant, Equipment (Net) | - - | - - | 1.00 | 8.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | 3.00 | - - | |
| Liabilities | - - | - - | 212.00 | 29.00 | |
|
Current
|
- - | - - | 13.00 | 24.00 | |
| Accounts Payable | - - | - - | 2.00 | - - | |
| Short Term Debt | - - | - - | - - | 1.00 | |
| Deferred Revenue | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | - - | |
| Other Current Liabilities | -1.00 | -3.00 | 6.00 | 18.00 | |
|
Non Current
|
- - | - - | 199.00 | 4.00 | |
| Long Term Debt | - - | - - | - - | 4.00 | |
| Leasing Obligations | - - | - - | - - | 4.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | |
| Other Non Current Liabilities | - - | - - | 199.00 | - - | |
| Equity | - - | - - | -115.00 | 452.00 | |
| Stockholders' Equity | - - | - - | -115.00 | 452.00 | |
| Retained Earnings | - - | - - | -116.00 | -206.00 | |
| Common Stock | - - | - - | - - | - - | |
| Preferred Stock | 58.00 | 166.00 | 133.00 | - - | |
| Profit | - - | - - | -51.00 | -89.00 | |
| Dividends | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | |
| Other Stockholders' Equity | -58.00 | - - | -131.00 | 659.00 | |
| Loss Other Compr. Income | - - | -166.00 | - - | - - |